Gapping down
In reaction to disappointing earnings/guidance: SWHC -11.1%, DAEG -10.9%, YGE -4.8%, CHS -4.7%, SDRL -4.2%, TIVO -2.2%, (announces new $350 mln share repurchase plan), SLH -1.6%, BMRN -1.3%, (adjusted guidance to reflect one-time sale item), DY -1.2%, BF.B -0.8%
M&A news: COV -1.5% (investor has filed lawsuit to block Medtronic (MDT) deal, according to reports)
Other news: TLM -4.1% (seeing reports that co's discussions with Repsol (REPYY) regarding a potential deal for the sale of assets have stalled), RGR -3.5% (following SWHC results), AR -0.8% (co raised its production guidance and 2014 capital budget to $3.7 bln), OWW -0.5% (OWW issues statement regarding American Airlines action; Orbitz for Business is not impacted)
Analyst comments: LEJU -4.4% (downgraded to Neutral from Buy at Goldman), RGR -3.5% (downgraded to Fair Value from Buy at CRT Capital, also in sympathy with SWHC), EJ -2.7% (downgraded to Neutral from Buy at Goldman), FB -0.5% (downgraded to Neutral from Buy at Janney)
In reaction to disappointing earnings/guidance: SWHC -11.1%, DAEG -10.9%, YGE -4.8%, CHS -4.7%, SDRL -4.2%, TIVO -2.2%, (announces new $350 mln share repurchase plan), SLH -1.6%, BMRN -1.3%, (adjusted guidance to reflect one-time sale item), DY -1.2%, BF.B -0.8%
M&A news: COV -1.5% (investor has filed lawsuit to block Medtronic (MDT) deal, according to reports)
Other news: TLM -4.1% (seeing reports that co's discussions with Repsol (REPYY) regarding a potential deal for the sale of assets have stalled), RGR -3.5% (following SWHC results), AR -0.8% (co raised its production guidance and 2014 capital budget to $3.7 bln), OWW -0.5% (OWW issues statement regarding American Airlines action; Orbitz for Business is not impacted)
Analyst comments: LEJU -4.4% (downgraded to Neutral from Buy at Goldman), RGR -3.5% (downgraded to Fair Value from Buy at CRT Capital, also in sympathy with SWHC), EJ -2.7% (downgraded to Neutral from Buy at Goldman), FB -0.5% (downgraded to Neutral from Buy at Janney)